Fund Evaluator:
Astoria US Equal Weight Quality KingsETF (ROE)Equity
Global Asset Class
U.S. Equity
Fund Group
Large Blend
Category
$0.000
NAV (as of )
$0.00
Minimum Initial
0.49% C
Expense Ratio
$268 Mil
Assets
Open
Status
na
12b-1 Fee
1.01%
TTM Yield
0.00%
Max Load
na
Portfolio Turnover
Best Performing in Large Blend Over the Last Year
| 49.8% | PRIMECAP Odyssey Growth (POGRX) |
| 48.6% | Vanguard PRIMECAP Core Inv (VPCCX) |
| 45.8% | Vanguard PRIMECAP Adm (VPMAX) |
| 45.7% | Vanguard PRIMECAP Inv (VPMCX) |
| 42.3% | Midas Special Opportunities (MISEX) |
Data as of 7/31/2026
-1.0% D
1-Mo Return
7.5% A
3-Mo Return
20.1% A
YTD Return
31.8% A
1-Yr Return
20.3% A
3-Yr Return
na
5-Yr Return
1.08 F
Category Risk Index
1.19
Total Risk Index
Fund Details
Fund Family
Astoria Portfolio Advisors LLC
Inception Date
7/31/2023
Share Class Type
Equity Investment Style
Large-Cap
Blend
Bond Investment Style
na
Socially Responsible Fund
No
Index Fund
No
Benchmark Index
S&P 500 (TR) (1970): 100%
Additional Fund Details
Astoria US Equal Weight Quality KingsETF Overview
ROE Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| ROE Return (NAV) | -1.0% | 7.5% | 31.8% | 20.3% | na | na |
| ROE Grade | D | A | A | A | na | na |
| +/- Category | -1.4% | 3.4% | 14.4% | 2.9% | na | na |
| Large Blend Avg | 0.4% | 4.1% | 17.5% | 17.3% | 11.1% | 13.7% |
| ROE Tax Cost Ratio | na | na | 0.5% | 0.5% | na | na |
ROE Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| ROE Return (NAV) | 20.1% | 17.4% | 18.2% | na | na | na | na | na | na | na | na |
| ROE Grade | A | B | D | na | na | na | na | na | na | na | na |
| +/- Category | 10.8% | 1.5% | -3.8% | na | na | na | na | na | na | na | na |
| Large Blend Avg | 9.3% | 15.8% | 22.1% | 23.7% | -17.3% | 26.5% | 17.5% | 29.8% | -5.9% | 21.3% | 10.2% |
| Risk Measures | |
| Standard Deviation: | 14.6% |
| Total Risk Index: | 1.19 - Average |
| Category Risk Index: | 1.08 - High |
| Category Risk Grade: | F (84% Rank) |
| Beta: | 1.04 |
| R-Squared: | 87% |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Large-Cap Blend |
| Bond Investment Style: | na |
| Yield: | 1.0% |
| Dividend Distribution: | Quarterly |
| Cap Gains Distribution: | Annually |
| Total Assets: | $268 Mil |
| Fund Total Assets: | $ 268 Mil |
| Share Class Type: | |
| Portfolio Turnover: | na |
Management Team
| Number of Managers: 2 | |||
| Longest Tenure: 3.0 years | |||
| Average Tenure: 2.3 years | |||
| Managers (Year): Davi John (2023), Cerbone Nick (2025) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 103 |
| % in Top 10 Holdings: | 12.2% |
| Fund is Non-Diversified: | No |
| % in Foreign Issues: | 4.9% |
Portfolio Allocation |
|
| Domestic Stock: | 94.7% |
| Foreign Stock: | 4.9% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.2% |
| Cash: | 0.3% |
Purchase Information
| Fund Family: | Astoria Portfolio Advisors LLC |
| Phone Number: | 215-882-9983 |
| Website: | www.valueshares.com |
| Status: | Open |
| Inception Date: | July 31, 2023 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | na |
Expenses and Fees | |
| Expense Ratio (%): | 0.49% ( Rating : Avg ) |
| Category Average Expense Ratio (%): | 0.81% |
| Share Class: | Astoria US Equal Weight Quality KingsETF |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.